Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Richman

Showing results (151-160 of 792) with videos related to

Pageof 80
Sort By:
Journal of Virology|January 1, 1996
Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivoH Zhang, G Dornadula, Y Wu, et al.
AIDS (London, England)|July 1, 1992
Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study GroupR D Moore, J Keruly, D D Richman, et al.
The Journal of Infectious Diseases|December 1, 1992
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study GroupJ E Gallant, R D Moore, D D Richman, et al.
Diagnostic Microbiology and Infectious Disease|June 1, 1983
Detection of herpes simplex virus in clinical specimens by DNA hybridizationD C Redfield, D D Richman, S Albanil, et al.
Radiology|December 1, 1975
67Ga radionuclide imaging in Burkitt's lymphomaS D Richman, F Appelbaum, S M Levenson, et al.
The Journal of Infectious Diseases|December 1, 1993
A cross-sectional comparison of persons with syncytium- and non-syncytium-inducing human immunodeficiency virusS A Bozzette, J A McCutchan, S A Spector, et al.
AIDS (London, England)|November 7, 2015
No evidence of posttreatment control after early initiation of antiretroviral therapySara Gianella, Christy M Anderson, Douglas D Richman, et al.
Virology|December 1, 1994
2-LTR circular viral DNA as a marker for human immunodeficiency virus type 1 infection in vivoC D Pauza, P Trivedi, T S McKechnie, et al.
Archives of Internal Medicine|March 14, 1994
Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study GroupJ E Gallant, R D Moore, D D Richman, et al.
JAMA|February 22, 2018
Administrative Costs Associated With Physician Billing and Insurance-Related Activities at an Academic Health Care SystemPhillip Tseng, Robert S Kaplan, Barak D Richman, et al.
Pageof 80

Showing results (151-160 of 792) with videos related to

Sort By:
Pageof 80
Journal of Virology|January 1, 1996
Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivoH Zhang, G Dornadula, Y Wu, et al.
AIDS (London, England)|July 1, 1992
Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study GroupR D Moore, J Keruly, D D Richman, et al.
The Journal of Infectious Diseases|December 1, 1992
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study GroupJ E Gallant, R D Moore, D D Richman, et al.
Diagnostic Microbiology and Infectious Disease|June 1, 1983
Detection of herpes simplex virus in clinical specimens by DNA hybridizationD C Redfield, D D Richman, S Albanil, et al.
Radiology|December 1, 1975
67Ga radionuclide imaging in Burkitt's lymphomaS D Richman, F Appelbaum, S M Levenson, et al.
The Journal of Infectious Diseases|December 1, 1993
A cross-sectional comparison of persons with syncytium- and non-syncytium-inducing human immunodeficiency virusS A Bozzette, J A McCutchan, S A Spector, et al.
AIDS (London, England)|November 7, 2015
No evidence of posttreatment control after early initiation of antiretroviral therapySara Gianella, Christy M Anderson, Douglas D Richman, et al.
Virology|December 1, 1994
2-LTR circular viral DNA as a marker for human immunodeficiency virus type 1 infection in vivoC D Pauza, P Trivedi, T S McKechnie, et al.
Archives of Internal Medicine|March 14, 1994
Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study GroupJ E Gallant, R D Moore, D D Richman, et al.
JAMA|February 22, 2018
Administrative Costs Associated With Physician Billing and Insurance-Related Activities at an Academic Health Care SystemPhillip Tseng, Robert S Kaplan, Barak D Richman, et al.
Pageof 80